HCWB HCW Biologics Inc
Company Analysis
Latest News
🟢 HCW Biologics is trading 6.8% up today as shares rebound on FDA meeting request interest
HCW Biologics is trading at $2.67 (6.8% up) as shares recover from last week’s steep decline, bolstered by renewed investor focus on its regulatory...
HCW Biologics Bounces 11% on FDA Meeting Request — But Can a Preclinical Cancer Drug Prop Up a $6 Million Company?
Shares of HCW Biologics shifted sharply higher in pre-market trading Monday, rebounding 11.2% to $2.78 after a bruising five-session slide that cut the stock...
🟢 HCW Biologics is trading 11.2% up today as it rebounds from a sharp selloff following an FDA meeting request update
HCW Biologics is trading at $2.78 (11.2%) up today, rebounding after a sharp multi-day selloff that saw the price drop from above $4 to $2.50. • The move...
🟢 HCW Biologics is trading 6.4% up today as it bounces from a sharp multi-day selloff
HCW Biologics is trading at $2.66 (6.4% up) in pre-market, bouncing after a steep multi-day selloff from above $4 to $2.50. • The move follows recent...
🔴 HCW Biologics is trading 6% down today following recent FDA meeting request
• HCW Biologics is trading 6% down at $2.35 in after-hours trading, extending a sharp multi-day slide. • The move follows the company's announcement yesterday,...
🟢 HCW Biologics is trading 7.2% up today in a technical after-hours bounce
HCW Biologics is trading 7.2% up at $2.68 in after-hours action, staging a technical rebound after a sharp multi-day slide despite no new company-specific...
🔴 HCW Biologics is trading 11.1% down today, extending a steep multi-day slide
HCW Biologics is trading 11.1% down at $2.56, extending a steep multi-day slide amid continued downside momentum and profit-taking. • The stock has seen a...
🔴 HCW Biologics is trading 6.3% down today, extending a week of sharp declines
HCW Biologics is trading 6.3% down at $2.70 today, continuing a period of significant weakness despite a lack of new fundamental catalysts. • The stock has...
🔴 HCW Biologics is trading 10.0% down
HCW Biologics is trading at $3.01, down 10.0% from a comparison close of $3.35 during regular trading. This is a price-action follow-up, so a separate catalyst...
🔴 HCW Biologics is trading 11.0% down
HCW Biologics is trading at $3.41, down 11.0% from a comparison close of $3.83 during regular trading. This is a price-action follow-up, so a separate catalyst...
🔴 HCW Biologics is trading 5.2% down today on apparent profit-taking despite broader biotech gains
HCW Biologics is trading 5.2% down today at $3.63 on apparent profit-taking, as the stock’s decline contrasts with a rising biotech sector and a broader...
🟢 HCW Biologics is trading 5.4% up today as biotech sentiment improves
HCW Biologics is trading at $4.03 (up 5.4%), rebounding from recent weakness as sentiment improves across the biotech and growth sectors. • The move aligns...
🟢 HCW Biologics is trading 10.5% up today amid broader risk-on sentiment
HCW Biologics is trading at $4.23 (+10.49%) in pre-market, rebounding from its July 20 close of $3.83 amid broader risk-on sentiment and gains in the...
🔴 HCW Biologics Inc is trading 5.00% down
HCWB is trading at $3.80, down 5.00%.
🟢 HCW Biologics is trading 10.0% up
HCW Biologics is trading at $4.40, up 10.0% from a comparison close of $4.00 during pre-market. This is a price-action follow-up, so a separate catalyst may...
🔴 HCW Biologics is trading 5.2% down today as traders take profits following recent sharp gains
HCW Biologics is trading 5.2% down at $4.08 as investors lock in profits following a period of high volatility driven by micro-cap trading dynamics rather than...
🟢 HCW Biologics is trading 5.1% up today despite no clear catalyst
HCW Biologics is trading at $4.52 (+5.12%) in pre-market after no clear company-specific catalyst surfaced in the available news flow. • Recent coverage has...
🟢 HCW Biologics Inc is trading 9.42% up in pre-market
HCWB is trading at $4.84, up 9.42% in pre-market.
🟢 HCW Biologics is trading 5.1% up today as post-split volatility continues
HCW Biologics is trading 5.1% up at $4.88 in pre-market, extending the sharp volatility seen since its 1‑for‑6 reverse stock split became effective on June 30,...
🔴 HCW Biologics is trading 5.9% down today as it retraces post-split gains
HCW Biologics is trading 5.9% down at $4.37 in pre-market, giving back a portion of the gains triggered by its recent reverse stock split. • The company...